ArticleOPEN ACCESS

Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al.

Cardiovascular Drugs and Therapy
DOI: 10.1007/s10557-018-6803-0
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Mathew, R. O., Gosmanova, E. O., & Sidhu, M. S. (2018, June 1). Targeting Cardiovascular Disease in Patients with Chronic Kidney Disease: Is Primary Prevention with Aspirin Ready for Prime Time?: Editorial to: “Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: A Multicenter Randomized Clinical Trial (AASER Study)” by M. Goicoechea et al. Cardiovascular Drugs and Therapy. Springer New York LLC. https://doi.org/10.1007/s10557-018-6803-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free